Regenerative Medicine

MaRS Regenerative Medicine Industry Report
With its deep research strength, strong international collaborations and unique aggregated approach to intellectual property development, Canada is ripe with commercial potential in the field of regenerative medicine, according to this Regenerative Medicine Industry Report. This report – the first in a series of sector analyses to come from MaRS – examines a range of criteria in the regenerative medicine industry, including government funding and support, world-class scientific research, coordinated commercialization strategy, regulatory environment and legislative constraints and...

Read More

• Email Page
• Print Page
• Increase Font
• Decrease Font

MaRS BLOG

• Fail to design = design to fail

See more articles

MaRS FACTS

MaRS was created in 2000 by a group of visionary business and community leaders concerned about Canada’s performance in the innovation economy.